Aramark Falls Short of Fiscal Q4 2026 Estimates as Revenue Rises 4.8% to $5.29B
Revenue of $5.29B vs. $5.30B expected and adjusted EPS of $0.71 vs. $0.76; revenue up 4.8% from a year earlier.
Aramark (ARMK) fell short of estimates for the fiscal fourth quarter of 2026. Revenue was $5.29 billion, up 4.8% from a year earlier, in line with the $5.30 billion estimate, and adjusted EPS was $0.71, up 11% from a year earlier, below the $0.76 estimate.
Shares fell 0.6% in premarket trading as of 6:31 a.m. ET, to $53.60 from a $53.94 close.
Fiscal Q4 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.76 | $0.71 | Miss by 6.0% |
| Revenue | $5.30B | $5.29B | In line |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 11% | ▲ 37% |
| Revenue | ▲ 4.8% | ▲ 5.3% |
By our calculation, adjusted EPS was $0.05 below it. The QoQ column compares with the previous quarter's revenue of $5.03 billion and adjusted EPS of $0.52. The YoY column compares with $5.05 billion and $0.64 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 5 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $5.05 billion, $4.83 billion, $4.81 billion, $5.03 billion and $5.29 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.64 and revenue of $5.27 billion next quarter, based on 6 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 4.8% increase to $5.29 billion.
- Estimate record. Whether Aramark extends a record of beating EPS estimates in 5 of its last 8 reports.
- Related coverage. See our reports on Inhibrx Biosciences, HawkEye 360, Almonty Industries and TMC the metals.
Sources: Results are from Aramark's Nov. 16, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Aramark's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
